Bernadette Redd

机构：National Cancer Institute, National Institutes of Health Clinical Center · ORCID：0000-0001-9058-9485

发表论文 82 篇 · 总被引 795 次 · h-index 12

代表论文

• Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer (2024 · New England Journal of Medicine · 被引 46)
• The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial (2024 · Nature Communications · 被引 44)
• Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors (2024 · Journal of Clinical Oncology · 被引 25)
• Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab (2025 · Gut · 被引 21)
• The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering Committee (2024 · European Urology · 被引 14)
• Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study (2024 · Alimentary Pharmacology & Therapeutics · 被引 12)